- Home
- DOCN vs OGN Comparison
DOCN vs OGN Comparison
Compare DOCN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCN
- OGN
- Stock Information
- Founded
- DOCN 2011
- OGN 1923
- Country
- DOCN United States
- OGN United States
- Employees
- DOCN N/A
- OGN N/A
- Industry
- DOCN Retail: Computer Software & Peripheral Equipment
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- DOCN Technology
- OGN Health Care
- Exchange
- DOCN Nasdaq
- OGN Nasdaq
- Market Cap
- DOCN 2.5B
- OGN 2.5B
- IPO Year
- DOCN 2021
- OGN N/A
- Fundamental
- Price
- DOCN $28.30
- OGN $9.59
- Analyst Decision
- DOCN Buy
- OGN Hold
- Analyst Count
- DOCN 14
- OGN 4
- Target Price
- DOCN $40.62
- OGN $18.00
- AVG Volume (30 Days)
- DOCN 1.5M
- OGN 3.5M
- Earning Date
- DOCN 08-05-2025
- OGN 08-05-2025
- Dividend Yield
- DOCN N/A
- OGN 0.84%
- EPS Growth
- DOCN 119.67
- OGN N/A
- EPS
- DOCN 1.14
- OGN 2.88
- Revenue
- DOCN $806,588,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- DOCN $15.19
- OGN N/A
- Revenue Next Year
- DOCN $13.99
- OGN $1.11
- P/E Ratio
- DOCN $24.92
- OGN $3.33
- Revenue Growth
- DOCN 13.21
- OGN N/A
- 52 Week Low
- DOCN $25.45
- OGN $8.01
- 52 Week High
- DOCN $47.02
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- DOCN 51.35
- OGN 46.81
- Support Level
- DOCN $27.87
- OGN $9.74
- Resistance Level
- DOCN $30.37
- OGN $10.27
- Average True Range (ATR)
- DOCN 0.90
- OGN 0.36
- MACD
- DOCN 0.10
- OGN -0.02
- Stochastic Oscillator
- DOCN 56.55
- OGN 20.22
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.